Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Leukemia & Lymphoma|June 11, 2021
Proteomic analysis in diffuse large B-cell lymphoma identifies dysregulated tumor microenvironment proteins in non-GCB/ABC subtype patientsSusanne Bram Ednersson, Mimmie Stern, Henrik Fagman, et al.
Leukemia & Lymphoma|February 19, 2016
Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot studyMartin Stenson, Anders Pedersen, Sverker Hasselblom, et al.
Leukemia & Lymphoma|August 26, 2011
Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy eraSverker Hasselblom, Martin Stenson, Olle Werlenius, et al.
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
Home treatment of deep vein thrombosis. An out-patient treatment model with once-daily injection of low-molecular-weight heparin (tinzaparin) in 555 patientsLeif Lapidus, Jens Börretzen, Martin Fahlén, et al.
British Journal of Haematology|May 17, 2018
Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patientsSusanne Bram Ednersson, Martin Stenson, Mimmie Stern, et al.
British Journal of Haematology|May 5, 2021
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based studyAmal Abu Sabaa, Charlott Mörth, Sverker Hasselblom, et al.
American Journal of Hematology|May 18, 2018
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphomaSara Ekberg, Mats Jerkeman, Per-Ola Andersson, et al.
Pageof 2